Summary Data on myelodysplastic syndromes (MDS) are seldom collected by cancer registries and unbiased findings from population-based studies remain rare. We report detailed information on MDS in a well-defined French population in the period 1980-1990. The crude incidence rate was 3.2 per 100 000 per year and no significant change in incidence was noted in the study period. The sex ratio was 1.9 and the male predominance was present in all age groups. We observed a rise in incidence after 60 years of age but no significant change in incidence of MDS as a whole was observed over the period studied. Refractory anaemia with excess of blasts (RAEB) was the most frequent subtype. Overall 5 year transformation rate of MDS was 31% (±4%) but it was 100% in RAEB in transformation. The observed 5 year survival rate was 23% + 3% and the corresponding corrected rate was 33%. The prognosis of RAEB in transformation was worse than the prognosis of other subtypes (P<0.01). Discrepancies with epidemiological data from other European countries are discussed.
The myelodysplastic syndromes (MDS) are a heterogeneous group of acquired haematological disorders. They are all characterised by quantitative and qualitative defects within one to three cell lines arising from the malignant transformation of a multipotent stem cell (Janssen et al., 1989) . Despite this, MDS were not considered as malignancies in the ninth International Classification of Diseases (ICD-9) (WHO, 1977) . This situation explains why data on MDS are rarely collected by cancer registries. So knowledge on epidemiological characteristics of MDS is often based on statistics from selected populations, mainly hospital-based statistics (Reizenstein and Dabrowski, 1991) . Unbiased results from population-based registries remain rare (Cartwright et al., 1990; Aul et al., 1992; Williamson et al., 1994) . The Registry of Haematopoietic Malignancies of the Cote d'Or (France) area provides detailed information on MDS since 1980. The purpose of this study was to provide information on incidence and prognosis of MDS in a welldefined French population.
Materials and methods
The department of Cote d'Or is located in Burgundy, France. The population was 493 931 inhabitants according to the 1990 census. In this population, 46% live in the urban centre of Dijon, 19% live in small towns and 35% live in rural areas (INSEE, 1991) . It is a relatively stable population with little migration and few foreigners (6%).
A population-based registry specialised in haematopoietic malignancies (HM) was created in 1980 in this area. Since then all HM, including MDS, diagnosed in this population, have been registered. The data presented consist of all patients in whom a MDS was diagnosed between January 1980 and December 1990. Information was collected from public and private biology and pathology laboratories, public and private hospital departments, general physicians and death certificates. Registration took place under excellent conditions: all bone marrow smears were examined in the C6te d'Or's single laboratory of haematology; biological information existed for all cases and there was an average of three notifications per case, and the morbidity/mortality ratio was 2.4 (Carli et al., 1986) . The efficiency of the registry was confirmed by an audit by the National Institute for Health and Medical Research (INSERM) in 1989 and 1993. FAB classification of MDS was used i.e. refractory anaemia (RA), refractory anaemia with ring sideroblasts (RARS), refractory anaemia with excess of blasts (RAEB), refractory anaemia with excess of blasts in transformation (RAEB-t) and chronic myelomonocytic leukaemia (CMML) (Bennett et al., 1982 1980 and 1990 . They represented 9.5% of the 1754 registered cases of HM. The crude incidence rate was 3.2 per 100 000 per year (3.8 in men and 2.5 in women). The corresponding age-standardised rate was 1.7 per 100 000 per year (2.3 in men and 1.2 in women) (sex ratio, 1.9). Agespecific incidence rates are given in Figure 1 . There was a male predominance in all age groups. MDS were rare before the age of 60 (12% very probable that in some areas a bone marrow examination was not provided in all patients, especially when they are asymptomatic or stable or very old. For these reasons we think that real incidence of MDS is higher than that generally reported. The well-established health screening of the elderly in Dorset could also partly explain the repartition of MDS subtypes diagnosed in their population. They noted a higher proportion of often asymptomatic and quite stable MDS as RA and CMML. Consequently RAEB and RAEBt are less numerous. The greatest discrepancy is the number of RA: we found only 8% of RA compared with 21% and 43% in the other studies (Cartwright et al.. 1990; Aul et al., 1992 : Williamson et al.. 1994 ). An explanation could be the harshness of our criteria for including RA. In The male predominance as found in our study had already been pointed out (Cartwright et al.. 1990 : Aul et al.. 1992 . No previous report has examined urban and rural differences. Cartwright reported geographical variations in the UK but did not consider urban rural variations (Cartwright et al.. 1990) . The explanation for the higher incidence in urban areas is unknown: it may be the result of some unidentified occupational or environmental exposure or some artefact of the way the data were collected. In our register. the proportion of secondary MDS, due to previous chemotherapy amounted to 12.5% of all MDS.
A discrepancy between England and Germany and France concerns the trends. Important increases in incidence have been reported in England: a 2-fold increase between 1984 and 1988 and in Germany a 3-fold increase in incidence between the 1976-80 and the 1986-90 periods (Cartwright et al.. 1990 : Aul et al.. 1992 . In France incidence rates increased but not so rapidly at the beginning of the decade and have remained stable since [1988] [1989] (Figure 1) . In Dusseldorf. they also noted that the rates are quite stable in the later years studied (Aul et al.. 1992) . The increase generally observed coincided with the publication in 1982 of the FAB classification, which was responsible for a better knowledge and an easier diagnosis of MDS (Bennett et al.. 1982 (Fenaux et al., 1987 : Mufti et al., 1985 : Tricot et al., 1984 . This discrepancy could be owing to selection bias in a haematological centre. as opposed to population-based registries which include all diagnosed cases. In RARS the 5 year transformation rate was quite low whereas the survival rate was bad. The evolution of each MDS subtype was different and the follow-up and the therapeutic attitude have to be adjusted. Epidemiological studies are necessary not only to establish epidermiological features useful for public health attitudes but also to define prognosis factors and generate suitable therapeutic schemes. This is particularly true in western countries where the elderly population is becoming more and more important.
